All Stories

  1. Alginate microencapsulated human hepatocytes for the treatment of acute liver failure in children
  2. Improving engraftment of hepatocyte transplantation using alpha-1 antitrypsin as an immune modulator
  3. Methylcellulose as a scaffold in the culture of liver-organoids for the potential of treating acute liver failure
  4. Transient Elastography Measurements of Spleen Stiffness as a Predictor of Clinically Significant Varices in Children
  5. A New High Throughput Screening Platform for Cell Encapsulation in Alginate Hydrogel Shows Improved Hepatocyte Functions by Mesenchymal Stromal Cells Co-encapsulation
  6. Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
  7. Paediatric fatty liver disease (PeFLD): All is not NAFLD – Pathophysiological insights and approach to management
  8. Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non-alcoholic fatty liver disease
  9. Health Related Quality of Life and Neurocognitive Outcomes in the First Year after Pediatric Acute Liver Failure
  10. Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine
  11. Cryopreserved neonatal hepatocytes may be a source for transplantation: Evaluation of functionality toward clinical use
  12. Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
  13. Human hepatocyte transplantation for liver disease: current status and future perspectives
  14. Fifteen-minute consultation: liver disease in children
  15. Autoimmune Liver Disease in Children with Sickle Cell Disease
  16. Systematic Review
  17. Allograft steatosis in the midst of the epidemic of obesity: Are children in the honeymoon period?
  18. Interim assessment of liver damage in patients with sickle cell disease using new non-invasive techniques
  19. Instant Blood-Mediated Inflammatory Reaction in Hepatocyte Transplantation: Current Status and Future Perspectives
  20. AST-to-platelet ratio index in non-invasive assessment of long-term graft fibrosis following pediatric liver transplantation
  21. Assessment of Diet and Physical Activity in Paediatric Non-Alcoholic Fatty Liver Disease Patients: A United Kingdom Case Control Study
  22. Bile Acids As Biomarkers - Liver And Gut Cross Talk in NAFLD
  23. Nonalcoholic Fatty Liver Disease
  24. Coculture with Mesenchymal Stem Cells Results in Improved Viability and Function of Human Hepatocytes
  25. Scanning the Scars
  26. Hepatopathy of Mauriac syndrome: a retrospective review from a tertiary liver centre
  27. Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future
  28. Management of Cholestatic Pruritus in Paediatric Patients With Alagille Syndrome
  29. Chronic Acetaminophen Exposure in Pediatric Acute Liver Failure
  30. Transient Elastography Is a Useful Noninvasive Tool for the Evaluation of Fibrosis in Paediatric Chronic Liver Disease
  31. Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease
  32. Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease
  33. Serum Levels of CK18 M30 and Leptin Are Useful Predictors of Steatohepatitis and Fibrosis in Paediatric NAFLD
  34. Predictive Value of Bile Duct Dimensions Measured by Ultrasound in Neonates Presenting With Cholestasis
  35. Fatty liver disease in children: eat now pay later
  36. Human hepatocyte transplantation: state of the art
  37. Crigler–Najjar syndrome: therapeutic options and consequences of mutations in the UGT1A1 complex
  38. The Incidence of Cyclic Vomiting Syndrome in Children: Population-Based Study.
  39. Outcome for children with cyclical vomiting syndrome
  40. A confused child: Answer
  41. A confused child: Question